Based on the above gene expression alterations indicative of decreased quiescence, we investigated whether peripheral blood CD8+ T cells from patients with NSCLC show phenotypic signatures following such genetic alterations. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.